A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/22 (2006.01) A61K 38/24 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2454181
The use of corticotroph-derived glycoprotein hormone (CGH) to induce lipolysis, treat obesity, insulin resistance, and type II diabetes is described.
L'invention concerne l'utilisation de l'hormone glycoprotéique corticotrope (CGH) pour induire la lipolyse et traiter l'obésité ainsi que la résistance à l'insuline et les diabètes type II.
Kelly James D.
Webster Philippa J.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Zymogenetics Inc.
LandOfFree
Use of corticotroph-derived glycoprotein hormone to induce... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of corticotroph-derived glycoprotein hormone to induce..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of corticotroph-derived glycoprotein hormone to induce... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1509287